Inflammatory and Hemostatic Markers in COVID-19 Patients with Arterial Thrombosis Are Significantly Lower at Hospital Admission than in COVID-19 Patients without Thrombosis

• Published in: Viruses 2022-10, Vol.14 (11), p.2330
• Main Authors: de Oliveira, Miguel, Cubal, Francisco, Coutinho, Maria, Pereira, Mónica, Cruz, Eugénia, Morais, Sara
• Format: Article
• Language: English
• Subjects: arterial thromboembolism; Automation; Biological markers; Biomarkers; Case reports; Coronaviruses; COVID-19; COVID-19 - diagnosis; Cytokine storm; Diagnosis; Endothelium; Ferritin; Fibrinogen; hemostatic markers; Hemostatics; Hospital patients; Hospitalization; Hospitals; Humans; Infections; Inflammation; inflammatory markers; Laboratories; Monocytes; Mortality; Patients; Prognosis; Retrospective Studies; Risk factors; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Statistical analysis; Statistics; Thromboembolism; Thrombosis; Thrombosis - epidemiology; venous thromboembolism; Venous Thromboembolism - epidemiology; Venous Thromboembolism - etiology
• ISSN: 1999-4915; 1999-4915
• DOI: 10.3390/v14112330

Patients with Coronavirus disease 2019 (COVID-19) are at increased risk of venous thromboembolism (VTE); however, data on arterial thromboembolism (ATE) is still limited. We report a case series of thromboembolic events (TE) in 290 COVID-19 patients admitted between October and December 2020 to a Portuguese hospital. Admission levels of various laboratory parameters were evaluated and compared between COVID-19 patients with (TE) and without thrombotic events (non-TE). The overall incidence of isolated ATE was 5.52%, isolated VTE was 2.41% and multiple mixed events was 0.7%. A total of 68% events were detected upon admission to the hospital with 76% corresponding to ATE. Admissions to the Intensive Care Unit were higher in patients with TE, when comparing with the non-TE group (44% vs. 27.2%; = 0.003). Patients with ATE presented significantly lower levels of CRP ( = 0.007), ferritin ( = 0.045), LDH ( = 0.037), fibrinogen ( = 0.010) and higher monocyte counts ( = 0.033) comparatively to the non-TE patients. These results point to an early occurrence of TE and an increased incidence of ATE over VTE. The less prominent inflammation markers in patients with TE and the early presence of TE in patients with otherwise no reason for hospitalization, may suggest a direct role of SARS-CoV-2 in the thrombotic process.